You are here: Home » News-CM » Companies » News
Business Standard

Zydus receives final approval for Desvenlafaxine Extended Release Tablets

Capital Market 

From USFDA

Zydus Cadila has received the final approval from USFDA to market Desvenlafaxine Extended Release Tablets, 50 mg and 100 mg. The drug is used to treat major depression and will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, October 12 2017. 13:11 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU